A new peer-reviewed study found that every single COVID-19 vaccinated participant examined had Thioflavin-T–positive, fibrinolysis-resistant amyloid microclots
circulating in their blood. Hidden in the supplementary tables is a demographic and biochemical pattern that completely reframes the paper:

94% of all participants were vaccinated.
100% of these vaccinated individuals had amyloid microclots — including every “healthy control.”

The condition labeled “Long COVID” occurred almost entirely in a heavily vaccinated population, without any laboratory confirmation of prior SARS-CoV-2 infection. In reality, the study is observing Long VACCINE pathology, not Long COVID. And because the authors’ own mechanistic experiments show that purified spike protein alone produces these amyloid, fibrinolysis-resistant clots, the implications are profound. The authors confirmed that Spike protein directly induces amyloid microclot formation, corroborating previous studies.

A breakthrough in-vitro study has shown that nattokinase — a natural enzyme from fermented soybeans — dissolves 84% of amyloid microclots within two hours, while also reducing overall clot burden and amyloid intensity. Even at lower doses, it produced large, dose-dependent reductions in total clot numbers and amyloid signal.